Trial intelligence / Profile preview

Topical Folic Acid for Oral Ulcers

NCT04989049Phase 1Unknown

Sponsor
Dow University of Health Sciences
Start
Sep 2022
Primary completion
Nov 2022
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

Phase 1, randomised, double-blind trial in Oral ulcer comparing Folic Acid Group with Placebo Group (2 arms). Primary endpoint: Healing of Ulcers at 7 days. Status: unknown.

02

Drugs

folic acid
03

Conditions

Oral ulcer

Beyond the preview

Go deeper on NCT04989049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04989049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call